Form 4: 2seventy bio CEO William Baird III Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4


William Baird III, CEO of 2seventy bio, Inc., sold 5,092 shares of common stock on March 17, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Summary

  • On March 17, 2025, William Baird III, the President and CEO of 2seventy bio, Inc., sold 5,092 shares of the company's common stock.
  • The shares were sold at a price of $4.945 per share.
  • The transaction was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
  • Following the transaction, Baird directly owns 1,121,034 shares of 2seventy bio, Inc.

Sentiment

Score: 5

Explanation: This is a neutral transaction related to tax obligations. It doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

This is a routine transaction related to executive compensation and tax obligations. It is common for executives to sell shares to cover taxes when restricted stock units vest.

Key Dates

DateDescription
03/17/2025Date of the stock sale transaction.
03/19/2025Date of signature by Attorney-in-Fact.

Keywords

2seventy bio, TSVT, William Baird III, stock sale, Form 4, insider trading, restricted stock units, tax withholding

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.